The Centers for Medicare and Medicaid Services (CMS) has approved the implants for New Technology Add-on Payment (NTAP).

Positive results from its Phase III STEER study mean Novartis could boost sales of its OAV101 IT drug for spinal muscular ...

Researchers found spinal disinhibition in people with fibromyalgia, adding new clues about the role of central pain ...

NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...

The ARC-EX stimulator, recently approved by the FDA, makes it easier for the spinal cord to hear what the brain wants to do ...

A Rajya Sabha MP urges the health minister to enable local production of Risdiplam, a vital drug for spinal muscular atrophy, ...

Laminectomy is a type of spinal decompression surgery where a ... such as physical therapy and prescription medications. If they don't help, then they could suggest a laminectomy.

Onward Medical today announced the first commercial sales of its ARC-EX spinal cord stimulation system (SCS) in the U.S.

IMC-2017 is under clinical development by ImmuneCyte and currently in Phase I for Spinal Cord Disorders. According to GlobalData, Phase I drugs for Spinal Cord Disorders have an 86% phase transition ...

DiFusion Technologies earned a new U.S. patent for four methods to manufacture its ZFuze biomaterial for orthopedic implants.